- Sánchez-García, S.; Jaén, R.I.; Lozano-Rodríguez, R.; Avendaño-Ortiz, J.; Pascual-Iglesias, A.; Hurtado-Navarro, L.; López-Collazo, E.; Boscá, L.; Prieto, P. "Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers.". Front Immunol. 15(): 1509188. (2024). (PMID: 39916956).
 
- Sánchez-García, S.; Povo-Retana, A.; Marin, S.; Madurga, S.; Fariñas, M.; Aleixandre, N.; Castrillo, A.; de la Rosa, J.V.; Alvarez-Lucena, C.; Landauro-Vera, R.; Prieto, P.; Cascante, M.; Boscá, L. "Immunometabolic Effect of Nitric Oxide on Human Macrophages Challenged With the SARS-CoV2-Induced Cytokine Storm. A Fluxomic Approach.". Adv Healthc Mater. (): e2401688. (2024). (PMID: 39502019).
- Sánchez-García, S.; Castrillo, A.; Boscá, L.; Prieto, P. "Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition.". Antioxidants (Basel). 13(11): . (2024). (PMID: 39594443).
- Sánchez-García, S.; Jaén, R.I.; Fernández-Velasco, M.; Delgado, C.; Boscá, L.; Prieto, P. "Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond.". Pharmacol Res. 197(): 106982. (2023). (PMID: 37925045).
- Povo-Retana, A.; Fariñas, M.; Landauro-Vera, R.; Mojena, M.; Alvarez-Lucena, C.; Fernández-Moreno, M.A.; Castrillo, A.; de la Rosa Medina, J.V.; Sánchez-García, S.; Foguet, C.; Mas, F.; Marin, S.; Cascante, M.; Boscá, L. "Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity.". Front Immunol. 14(): 1211068. (2023). (PMID: 37675104).
- Povo-Retana, A.; Landauro-Vera, R.; Fariñas, M.; Sánchez-García, S.; Alvarez-Lucena, C.; Marin, S.; Cascante, M.; Boscá, L. "Defining the metabolic signatures associated with human macrophage polarisation.". Biochem Soc Trans. (): . (2023). (PMID: 37449892).
- Povo-Retana, A.; Sánchez-García, S.; Alvarez-Lucena, C.; Landauro-Vera, R.; Prieto, P.; Delgado, C.; Martín-Sanz, P.; Boscá, L. "Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair.". Purinergic Signal. (): . (2023). (PMID: 37052777).
- Paz-García, M.; Povo-Retana, A.; Jaén, R.I.; Prieto, P.; Peraza, D.A.; Zaragoza, C.; Hernandez-Jimenez, M.; Pineiro, D.; Regadera, J.; García-Bermejo, M.L.; Rodríguez-Serrano, E.M.; Sánchez-García, S.; Moro, M.A.; Lizasoaín, I.; Delgado, C.; Valenzuela, C.; Boscá, L. "Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction.". Biomed Pharmacother. 158(): 114214. (2023). (PMID: 36916435).
- Jaén, R.I.; Povo-Retana, A.; Rosales-Mendoza, C.; Capillas-Herrero, P.; Sánchez-García, S.; Martín-Sanz, P.; Mojena, M.; Prieto, P.; Boscá, L. "Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release.". Int J Mol Sci. 23(16): . (2022). (PMID: 36012389).
- Val-Blasco, A.; Prieto, P.; Jaén, R.I.; Gil-Fernández, M.; Pajares, M.; Domenech, N.; Terrón, V.; Tamayo, M.; Jorge, I.; Vázquez, J.; Bueno-Sen, A.; Vallejo-Cremades, M.T.; Pombo-Otero, J.; Sanchez-García, S.; Ruiz-Hurtado, G.; Gómez, A.M.; Zaragoza, C.; Crespo-Leiro, M.G.; López-Collazo, E.; Cuadrado, A.; Delgado, C.; Boscá, L.; Fernández-Velasco, M. "Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation.". JACC Basic Transl Sci. 7(6): 544-560. (2022). (PMID: 35818504).
- Jaén, R.I.; Sánchez-García, S.; Fernández-Velasco, M.; Boscá, L.; Prieto, P. "Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases.". Front Immunol. 12(): 658840. (2021). (PMID: 33968061).
- Jaén, R.I.; Fernández-Velasco, M.; Terrón, V.; Sánchez-García, S.; Zaragoza, C.; Canales-Bueno, N.; Val-Blasco, A.; Vallejo-Cremades, M.T.; Boscá, L.; Prieto, P. "BML-111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis.". FASEB J.. (): . (2020). (PMID: 32543747).
|
Email:Info